Redefining women's health.

Gameto is a female-led biotech company developing treatment solutions to improve women's reproductive health throughout their lives: from egg freezing, infertility, and diseases of the reproductive years to menopause and conditions that occur afterward.

We are building treatment solutions to provide better options for women. 

Women's reproductive health is an underdeveloped area within the healthcare industry.

Despite a growing global infertility crisis, female reproductive therapies have remained largely unimproved since inception decades ago.

Until now.

We’ve developed a platform that is broadly applicable and has the potential to solve many gaps in the women’s health space. Our first focus is filling the massive gaps in the fertility space.

Creating transformative solutions for women’s health

The first application of our technology aims to improve the current IVF and egg freezing landscape. We are advancing technology in a space that has been virtually untouched since inception.

Scientists, Innovators, and Biotechnology Entrepreneurs

Our female-led team understands the burden women take when embarking on their reproductive journeys and is passionate about improving it. Our mission to redefine women's health guides everything we do.

Find out how to join us.

Latest news

News

What if We Could Get Rid of Menopause?

News

Gameto Named as 2023 Technology Pioneer by World Economic Forum

News

The Future of Fertility: A new crop of biotech startups want to revolutionize human reproduction.

News

Fertility treatments, closer to becoming cheaper?

Scientific Publications

Improved rescue of immature oocytes obtained from conventional gonadotropin stimulation cycles via human induced pluripotent stem cell-derived ovarian support cell co-culture

Scientific Publications

Human induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation

News

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

News

Reimagining Infertility – An Interview with Christian Kramme

Scientific Publications

Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression

News

Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University

News

Why it is key to anticipate to preserve fertility?

News

A healthcare brand for women begins to take shape

News

Forbes Under 30 Healthcare 2023: Fighting Cancer, Expanding Access To Care And Protecting Women's Health

News

Inception Fertility Partners with Leading Technology Companies on Breakthrough Studies to Advance Reproductive Medicine

Scientific Publications

Towards reconstituting an ovary

News

34 of the most promising women's health startups of 2022, according to VCs

News

Gameto, the biotech startup that uses cell engineering to treat with ovarian deterioration, arrives in Spain

News

Varsavsky chooses Madrid for the preclinical studies in Europe of his startup Gameto

News

Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics

News

Biotech Startup Gameto on Female Fertility and Aging

Scientific Publications

Efficient Human Germ Cell Specification from Stem Cells via Combinatorial Expression of Transcription Factors

News

Gameto, the startup that seeks to delay menopause, lands in Spain

News

Is it Time to Cancel Menopause?

News

The 20(+1) under 40: Your guide to the next generation of biotech leaders

News

Why aren’t VCs funding more startups focused on menopause?

Scientific Publications

Expanding homogeneous culture of human primordial germ cell-like cells maintaining germline features without serum or feeder layers

News

International Women’s Day: the wonderful women of longevity

News

Gameto founder talks menopause and female healthspan extension

News

Nature Is Sexist. Can Advances In Longevity Biotechnology Help Restore Reproductive Equality?

News

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells

Scientific Publications

An integrated pipeline for mammalian genetic screening